ALOSETRON Drug Patent Profile
✉ Email this page to a colleague
When do Alosetron patents expire, and when can generic versions of Alosetron launch?
Alosetron is a drug marketed by Amneal Pharms, Hibrow Hlthcare, Hikma, Mankind Pharma, Ph Health, and Rising. and is included in six NDAs.
The generic ingredient in ALOSETRON is alosetron hydrochloride. There are three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the alosetron hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alosetron
A generic version of ALOSETRON was approved as alosetron hydrochloride by AMNEAL PHARMS on December 22nd, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ALOSETRON?
- What are the global sales for ALOSETRON?
- What is Average Wholesale Price for ALOSETRON?
Summary for ALOSETRON
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for ALOSETRON |
| DailyMed Link: | ALOSETRON at DailyMed |
US Patents and Regulatory Information for ALOSETRON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 206647-001 | Dec 22, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mankind Pharma | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 213614-001 | Sep 9, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hibrow Hlthcare | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 211621-002 | Sep 16, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rising | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 209180-002 | Jan 14, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
